The Obesity Surgery Devices Market To Move To “Growth Absorption” Spectrum Betwe

Posted by Ashish on May 27th, 2021

According to a new market report published by Persistence Market Research “Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019” the global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.

Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems.

Get Going With Sample Of Microfluidic Devices Market Report! https://www.persistencemarketresearch.co/samples/2995

Some of the major players in the Microfluidic Device market:

  • Roche Diagnostics.
  • Abbott Laboratories.
  • Siemens Healthcare.
  • Agilent Technologies.
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation.
  • Johnson & Johnson.

How About Re-Inventing The Methodical Wheel In The Microfluidic Devices Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/2995

Like it? Share it!


Ashish

About the Author

Ashish
Joined: September 12th, 2019
Articles Posted: 582

More by this author